Skip to main content
. 2014 Mar 28;17(1):47–53. doi: 10.4048/jbc.2014.17.1.47

Figure 3.

Figure 3

Median survival time (MST) of recurrence free survival and survival after recurrence by cyclin D1 overexpression in patients with experienced recurrence. Cyclin D1 overexpression was not correlated with a difference in recurrence free survival (p=0.269) but significantly associated with increased survival after disease recurrence (p=0.012).

RFS=recurrence free survival.